
    
      After consent, laboratory and radiologic tests will be done and a baseline questionnaire will
      be completed. Participants will then be started on the protocol specific hormonal therapy for
      a total of 6 months. After 2 months of hormone therapy the participants will begin radiation
      therapy and concurrent docetaxel chemotherapy treatments.

      The radiation therapy will be delivered to a total dose of 66.0 Gy at 2.0 Gy/fraction (fx)
      once daily over 7 weeks, using either a 3-D conformal technique and/or intensity modulated
      radiation therapy (IMRT).

      Participants will receive docetaxel once a week for a total of 7 infusions with concurrent
      radiation therapy treatments. The weekly dose of docetaxel will be 20 mg/m2. Docetaxel will
      be given as an intravenous (IV) infusion over 30 minutes within â‰¤6 hours prior to the
      radiotherapy treatments.
    
  